For International Women in Science Day—and to mark the 10-year anniversary of Johnson & Johnson beginning to innovate in the fight against prostate cancer—Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer, Janssen Research & Development, shares the latest scientific strides being made in the battle against one of the most common cancers in men.

A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.

Some 20% of people diagnosed with the disease haven’t touched a cigarette. For Healthy Lung Month, scientists who’ve dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.

For Men’s Health Month, school yourself on the latest screenings and treatments for this most common male cancer.

This month, the celebrity entrepreneur steps away from the shark tank to partner with Johnson & Johnson Innovation on a healthcare project that hits close to home.

For National Cancer Prevention Month, we talked to a pair of top experts about common falsehoods about the disease—and what the latest science says about cancer prevention truths.